Announcements Trials
Browse Landscape

Status

Completed 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 48Observational 4

Sponsor

Cancer Type

Thoracic 4

Conditions

Small Cell Lung Carcinoma 4Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Unresectable Hepatocellular Carcinoma 1Squamous Cell Carcinoma of Head and Neck 1Sarcopenia 1Recurrent Squamous Cell Lung Carcinoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Oropharyngeal Neoplasms 1Non-Small Cell Lung Cancer NSCLC 1Neoplasms 1Melanoma 1Kidney Neoplasms 1Hepatobiliary Cancers 1Head and Neck Neoplasms 1Deglutition Disorders 1

Interventions

atezolizumab 5durvalumab 4Drug Therapy 4Carboplatin 4Psychiatric Rehabilitation 3Immunotherapy 3Topotecan 2Specimen Handling 2Radiotherapy 2Polymerase Chain Reaction 2PM 01183 2Observation 2Mental Status and Dementia Tests 2Magnetic Resonance Spectroscopy 2Immunohistochemistry 2Immune Checkpoint Inhibitors 2Ifosfamide 2Etoposide 2Cisplatin 2Biopsy 2trastuzumab deruxtecan 1nedaplatin 1X-Ray Therapy 1Watchful Waiting 1Vinorelbine 1Tomography, Optical Coherence 1Tissue Banks 1Therapeutics 1Radiation, Ionizing 1Phlebotomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × Small Cell Lung Carcinoma × durvalumab × Clear all
NCT05683977 2026-02-24

ARSENAL

AstraZeneca

Active not recruiting
254 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT06826677 2025-06-24

ARAL

AstraZeneca

Completed
71 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT04285866 2022-06-07

S-REAL

Fundación GECP

Completed
245 enrolled
Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

NCT04672759 2020-12-17

A Real-world Study of Durvalumab for Lung Cancer in China

Peking Union Medical College Hospital

Unknown
100 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡